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1 Ajoene is a garlic compound with anti-platelet properties and, in addition, was shown to inhibit
cholesterol biosynthesis by aecting 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA)
reductase and late enzymatic steps of the mevalonate (MVA) pathway.
2 MVA constitutes the precursor not only of cholesterol, but also of a number of non-sterol
isoprenoids, such as farnesyl and geranylgeranyl groups. Covalent attachment of these MVA-derived
isoprenoid groups (prenylation) is a required function of several proteins that regulate cell
proliferation. We investigated the eect of ajoene on rat aortic smooth muscle cell proliferation as
related to protein prenylation.
3 Cell counting, DNA synthesis, and cell cycle analysis showed that ajoene (1 – 50 mM) interfered
with the progression of the G1 phase of the cell cycle, and inhibited rat SMC proliferation.
4 Similar to the HMG-CoA reductase inhibitor simvastatin, ajoene inhibited cholesterol biosynthesis.
However, in contrast to simvastatin, the antiproliferative eect of ajoene was not prevented by the
addition of MVA, farnesol (FOH), and geranylgeraniol (GGOH). Labelling of smooth muscle cell
cellular proteins with [3H]-FOH and [3H]-GGOH was significantly inhibited by ajoene.
5 In vitro assays for protein farnesyltransferase (PFTase) and protein geranylgeranyltransferase
type I (PGGTase-I) confirmed that ajoene inhibits protein prenylation. High performance liquid
chromatography (HPLC) and mass spectrometry analyses also demonstrated that ajoene causes a
covalent modification of the cysteine SH group of a peptide substrate for protein PGGTase-I.
6 Altogether, our results provide evidence that ajoene interferes with the protein prenylation
reaction, an eect that may contribute to its inhibition of SMC proliferation.
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Introduction
Garlic (Allium sativum) has been advocated as a remedy for
the treatment and prevention of a number of diseases,
including atherosclerosis and cancer. However, several clinical
studies conducted during the last three decades have shown
contradictory lipid-lowering activity and beneficial eects on
cancer incidence (Agarwal, 1996; Buiatti et al., 1989; You et
al., 1989). Therapeutic actions of garlic, although still
discussed, have been attributed primarily to its organosul-
phuric compounds, but more detailed studies on chemically
defined garlic components are needed to better clarify its
pharmacological properties (Agarwal, 1996). In vitro and in
vivo studies have been conducted to evaluate the antiproli-
ferative activity of garlic and its constituents. For instance,
garlic extracts prepared from 1% alcoholic extraction of garlic
powder, containing a mixture of organosulphur compounds,
was found to inhibit [3H]-thymidine incorporation in cultured
trophoblasts and endothelial cells (Sooranna et al., 1997).
Further, development of spontaneous mammary tumours in
C3H mice has been shown to be inhibited by feeding fresh
garlic which contains active allinase (Kroning. 1964). Allinase
acts on alliin to produce allicin, the precursor for several
organosulphuric compounds including ajoene. Therefore,
allicin and/or its metabolites, rather than alliin may exert the
chemopreventive action of garlic (Kroning. 1964).
Ajoene (Figure 1) is a well-established antiplatelet agent,
and its inhibitory eect on platelet aggregation has been
extensively studied and documented both by in vivo and in
vitro experiments (Apitz-Castro et al., 1986a, b; 1988; 1991;
1994). Further, ajoene is a potent modulator of membrane-
dependent functions of immune cells, that are under control
of the signal-transduction system (Romano et al., 1997).
Beyond this action, recent evidence showed that ajoene
inhibits proliferation and induces apoptosis of several cancer
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cell lines, which ultimately leads to the reduction of tumour
growth in vivo (Li et al., 2002). Allicin and ajoene were also
reported to significantly decrease cholesterol biosynthesis in
rat hepatocytes and HepG2 cells by inhibiting HMG-CoA
reductase and late steps of the MVA pathway which leads to
the accumulation of the precursor lanosterol (Dirsch et al.,
1998; Gebhardt et al., 1994; Urbina et al., 1993). Mevalonate
(MVA) is the precursor not only for cholesterol but also for a
number of non-sterol isoprenoids, such as the farnesyl and
geranylgeranyl groups, which become covalently attached to
proteins that are essential for cell proliferation (Glomset et
al., 1990; Goldstein & Brown, 1990; Grunler et al., 1994).
Indeed, protein prenylation is required for membrane
association and therefore function of several proteins
involved in the regulation of cell proliferation, including
p21 ras (Grunler et al., 1994).
Thus, given the evidence for the requirement of MVA-
derived isoprenoids for cell growth, and for the ability of
ajoene to interfere with the MVA pathway (Gebhardt et al.,
1994), our study was undertaken to evaluate the eect of
ajoene on SMCs proliferation as related to protein prenyla-
tion. Our results show that ajoene inhibits SMCs proliferation
by interfering with the progression of the G1 phase of the cell
cycle. In addition, at similar concentrations, we observed an
inhibition of cholesterol biosynthesis and a decrease in the
incorporation of [3H]-FOH and [3H]-GGOH into cellular
proteins. In vitro assays for PFTase and PGGTase-I activities
confirmed the ability of ajoene to inhibit protein prenylation.
By reverse phase high performance liquid chromatography
(HPLC) and mass spectrometry analyses, we determined the
mechanism of inhibition of protein prenylation.
Methods
Materials
Eagle’s minimum essential medium (MEM), trypsin ethylen-
diaminetetraacetate, penicillin (10,000 U ml71), streptomycin
(10 mg ml71), tricine buer (1 M, pH 7.4) and non-essential
amino acid solution (1006) were purchased from Gibco, and
FCS was from Mascia Brunelli. Disposable culture flasks and
petri dishes were from Corning Glassworks, and filters were
from Millipore. [2-14C]-Acetate, sodium salt (58.9 mCi m-
mol71), [6-3H]-thymidine, sodium salt (2 Ci mmol71) and
molecular weight protein standards were from Amersham.
Isoton II was purchased from Instrumentation Laboratories.
All-trans FOH, was purchased from Sigma, and all-trans
geranyl-geraniol (GGOH) was kindly provided by Prodotti
Roche. SDS, TEMED, ammonium persulphate, glycine,
acrylamide solution (30% T, 2.6% C) were obtained from
Bio-Rad Laboratories. All-trans FOH [1-3H] (15 – 20 Ci m-
mol71), all-trans GGOH [1 – 3H] [50 – 60 Ci mmol71), all-
trans [3H]-FPP (20 Ci mmol71) and all-trans [3H]-GGPP
(20 Ci mmol71) were from American Radiolabeled Chemi-
cals. Avidin-agarose was from Pierce. Cytox Dye was
purchased from Molecular Probes. Ajoene (Figure 1), was
obtained as previously described (Apitz-Castro et al., 1983),
and dissolved in ethanol; control cells received the same
volume of the solvent (0.5% final concentration). Simvastatin
in its lactone form (Merck, Sharp & Dohme Research
Laboratories) was dissolved in 0.1 M NaOH to give the
active form, and the pH was adjusted to 7.4 by adding 0.1 M
HCl. The solution was sterilized by filtration.
Cell proliferation and DNA synthesis
Smooth muscle cells (SMC) were cultured from the intimal-
medial layers of aorta of male Sprague –Dawley rats as
previously described (Corsini et al., 1995).
Cell proliferation was evaluated by cell counting with a
Coulter Counter model ZM (Coulter Instruments) after
trypsinization of the monolayers (Corsini et al., 1993), and
DNA synthesis was estimated by nuclear incorporation of
[3H]-thymidine (Corsini et al., 1995).
Cell cycle analyses
Flow cytometry was utilized to analyse cell cycle distribution.
Cells were trypsinized and centrifuged for 5 min at
1000 r.p.m. Pellets were resuspended in 0.5 ml of permeabi-
lizing buer (0.5 mM in 100 mM Tris pH 7.4, 150 mM NaCl,
1 mM CaCl2, 0.5 mM MgCl2 0.1% NP-40) containing Cytox
Dye (final concentration 0.5 mM). Samples were placed in the
dark for 30 min and the green fluorescence of individual
nuclei was measured. Nuclear Cytox Dye fluorescence signal
was recorded on the FL1 channel of a FACS scan flow
cytometer (Becton Dickinson) and analysed with CellQuest
software. The number of cells in G0/G1, S and G2/M phases
was expressed as percentages of total events (10,000 cells).
Synthesis of total sterols
The synthesis of cholesterol was determined by measuring the
incorporation of radioactive acetate into cellular sterols
(Corsini et al., 1995).
Labelling of proteins with [3H]-FOH or [3H]-GGOH
and SDS –PAGE analyses
The prenylated proteins were analysed after incubation of the
cell monolayers with [3H]-FOH (10 mM) or [3H]-GGOH
(2.5 mM) for 5 h (see: ‘Experimental protocols’) (Corsini et
al., 1999; Ferri et al., 2001). After this time, cell monolayers
were scraped into 1.5 ml of phosphate buered saline (PBS)
containing 1 mM phenylmethylsulphonylfluoride, and the
resuspended cells collected and centrifuged (14,000 r.p.m.
63 min.). Cells pellets were delipidated with cold acetone
and two extractions with chloroform/methanol (2 : 1). The
delipidated proteins were solubilized in 3% SDS, 62.5 mM
Tris-HCl, pH 6.8, and an aliquot (40 mg protein) was
analysed by 12.5% SDS–PAGE (Corsini et al., 1999; Ferri
et al., 2001). The gel was treated with Amplify (Amersham)
and exposed to Kodak X-Omat-AR film at 7708C for 2 – 4
weeks. Fluorographic signals were analysed by densitometric
scanning.
Figure 1 Chemical structure of trans-ajoene [(E)-4,5,9-trithia-
dodeca-1,6,11-triene-9-oxide].
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Assays for inhibition of PFT and PGGT-I by ajoene
Recombinant rat PFTase and PGGTase-I were expressed in
the Sf9/baculovirus system and purified as described (Yokoya-
ma et al., 1997). The standard reaction mixture for PFTase
assay contains 0.75 mM (0.3 mCi) [3H]-FPP and 5 mM RAS-
CVIM in a total volume of 20 ml containing 30 mM potassium
phosphate, 0.5 mM MgCl2, 20 mM ZnCl2, pH 7.7. PGGTase-I
assay was carried out using 0.75 mM (0.3 mCi) [3H]-GGPP and
5 mM H-Ras-CVLL as substrates. Stock solutions of ajoene
were prepared in absolute ethanol, and a 1 ml aliquot was
added to the reaction mixture (final concentration of ethanol is
5%). Reactions were initiated by adding rat PFTase or
PGGTase-I (20 ng). After incubation at 308C for 20 min, the
reaction was terminated by adding 200 ml of 10% HCl in
ethanol. The amount of the prenylated protein product was
quantified by the glass fibre-filter method as described
previously (Pompliano et al., 1992). In some cases, 50 mM
biotinylated peptide substrates, biotin-lamine B peptide
(biotin-GTPRASNRSCAIS) and biotin-g6 peptide (biotin-
NPFREKKFFCAIL) were used as substrates of PFT and
PGGT-I, respectively. The amount of radioactivity transferred
to the peptides was determined by the method using avidin-
agarose as described (Yokoyama et al., 1991).
Analyses of products from incubation of ajoene and
biotin-g6 peptide by reverse-phase HPLC and
mass spectrometry
Ajoene (50 mM) and biotin-g6 peptide (25 mM) were incubated
at 308C for 30 min in a total volume of 200 ml containing
30 mM potassium phosphate, pH 7.7, 1 mM MgCl2, 20 mM
ZnCl2. The sample was subjected to HPLC on a C18 reverse-
phase column (Vydac 218TP52, 4.66250 mm). The column
was developed at a flow rate of 1 ml min with a solvent gradient
using 0.06% trifluoroacetic acid in water (solvent A) and
0.054% trifluoroacetic acid in acetonittrile (solvent B): 20 –
80% B over 60 min. The absorbance at 218 nm was monitored.
For mass spectrometry analyses, a mixture of ajoene
(500 mM) and biotin-g6 peptide (25 mM) was incubated at
308C for 30 min in a 200 ml mixture without buer or salt,
and an aliquot was infused into the electrospray mass
spectrometer (Bruker/Hewlett-Packard Esguire).
Statistical analyses
Experimental data are expressed as mean+s.d. The eects of
the tested compounds versus control on the dierent
parameters were analysed by a one-way ANOVA followed
by Bonferroni test. The concentration of compounds required
to inhibit 50% of cell proliferation, [3H]-thymidine incorpora-
tion and cholesterol biosynthesis (IC50) was calculated by
linear regression analyses of the logarithm of the concentra-
tion (in micromoles per litre) versus logit.
Results
Effect of ajoene on arterial SMC proliferation and cell
cycle progression
The antiproliferative action of ajoene was studied in rat
aortic SMCs at concentrations ranging from 1 to 50 mM. In
the first set of experiments, cell proliferation was measured
after 3 days of growth in the presence of increasing
concentrations of ajoene. Ajoene decreased SMC prolifera-
tion in a concentration-dependent manner with an IC50-value
of 5.7 mM (Figure 2A). In addition, ajoene inhibited [3H]-
thymidine incorporation in a concentration dependent
manner (IC50=25.2 mM)(Figure 2B). Similar potency of the
antiproliferative eect of ajoene was observed on three
dierent strains of rat SMC (data not shown).
To further investigate the antiproliferative eect of ajoene,
we performed cell cycle analyses by flowcytometry. Incuba-
tion of SMCs for 120 h with culture media containing 0.4%
FCS led to the accumulation of the cells in the G1 phase
(95.8%) with only a small percentage in the S phase (0.62%)
(Figure 3). As expected, 20 h after stimulation with 10%
FCS, the cells in S phase were increased to 5.8%, and those
in G1 phase were decreased to 83.9% (Figure 3). Incubation
of SMCs with ajoene led to the accumulation of cells in the
G1 phase in a concentration dependent manner, with a
complete inhibition at 25 mM concentration (Figure 3).
Importantly, we did not detect any significant increase in
the percentage of sub G0/G1 cells even after incubation with
25 mM ajoene, which indicates a specific interference with the
progression of the G1 phase of the cell cycle without
induction of apoptosis (Figure 3).
Effect of ajoene on the mevalonate pathway
It has previously been shown that ajoene inhibits cholesterol
biosynthesis by interfering with dierent steps of the MVA
pathway (Gebhardt et al., 1994). To study whether ajoene
inhibits SMCs proliferation by aecting one of the steps of
the MVA pathway, we evaluated the eect of this compound
versus the HMG-CoA reductase inhibitor simvastatin. We
Figure 2 Concentration-dependent eect of ajoene on proliferation
of rat aortic SMCs. (A) Cells were seeded (2006103/dish) and
incubated with Eagle’s MEM supplemented with 10% FCS; 24 h
later the medium was changed with one containing 0.4% FCS to stop
cell growth and the cultures were incubated for 48 h. At this time, the
medium was replaced with one containing 10% FCS and the reported
concentrations of ajoene and the incubation was continued for
further 72 h at 378C. Each bar represents the mean+s.d.mean of
three independent experiments. Inhibitor versus control: *P50.001
(Bonferroni test). (B) Cells were seeded at a density of 3006103/
dish71 and incubated with Eagle’s MEM supplemented with 10%
FCS; 24 h later, the medium was changed with one containing 0.4%
FCS to stop cell growth and the cultures were incubated for 120 h.
At this time, the medium was replaced with one containing 10% FCS
and the indicated concentrations of ajoene. After 20 h, at 378C,
labelled thymidine was added to the medium and the incubation
continued for further 2 h. Each bar represents the mean+s.d.mean of
three independent experiments. Inhibitor versus control: *P50.001
(Bonferroni test).
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first investigated their eects on cholesterol biosynthesis and
SMCs proliferation. As shown in Figure 4, ajoene strongly
inhibited cholesterol biosynthesis with an IC50 of 1.5 mM, and
at similar concentrations, it also inhibited SMCs prolifera-
tion. Under the same experimental conditions, at least 80%
inhibition of cholesterol biosynthesis was necessary to induce
a decrease in SMC proliferation by simvastatin (Figure 4)
(Corsini et al., 1993). These results suggest a dierent
antiproliferative’s mechanism by the two compounds.
We have previously shown that MVA, FOH, and GGOH,
counteract the antiproliferative eect on SMCs elicited by
HMG-CoA reductase inhibitors (statins) but not by the
protein prenylation inhibitor perillic acid (Corsini et al., 1995;
Ferri et al., 2001; Raiteri et al., 1997). As shown in Figure 5,
the antiproliferative eect of ajoene was not prevented by the
addition of MVA, FOH and GGOH, suggesting that its
action was directly related to the inhibition of protein
prenylation.
To study whether ajoene interferes with protein prenyla-
tion, the incorporation of [3H]-FOH and [3H]-GGOH into
cellular proteins was examined under the same experimental
conditions utilized for evaluating DNA synthesis (Ferri et al.,
2001). As shown in Figure 6, [3H]-FOH and [3H]-GGOH
were readily incorporated into specific proteins with
molecular weights ranging from 21 to 72 kDa, as reported
in previous studies (Corsini et al., 1999; Danesi et al., 1995;
Figure 3 Eect of ajoene on the cell cycle of rat aortic SMCs. Experimental conditions are as in Figure 1B. Flow cytometry
analysis of the cell cycle was performed in the presence of 0.4%, and 10% FCS alone, or in the presence of the indicated
concentrations of ajoene as described in ‘Methods’. FL-1: green fluorescence. The data shown are representative of two independent
experiments.
Figure 4 Eect of ajoene and simvastatin on cholesterol biosyn-
thesis and rat aortic SMCs proliferation. Experimental conditions are
as in Figure 1A [14C]-Acetate incorporation was used to assay
cholesterol biosynthesis, 72 h after its addition to the cells. Each
point represents the mean +s.d. of triplicate dishes. The mean value
for control experiments (without inhibitor) for cell proliferation was
14626103 (+916103) cells/dish and 19.35 (+2.37) pmol mg716h
for cholesterol biosynthesis, respectively. Inhibitor versus control:
*P50.05; **P50.001 (Bonferroni test). The data shown are
representative of two independent experiments.
Figure 5 Eect of mevalonate and its derivatives on proliferation of
rat aortic SMCs inhibited with ajoene or simvastatin. Experimental
conditions are as in Figure 1B. Each bar represents the mean+
s.d.mean of three independent experiments. Bonferroni test:
*P50.001, ajoene+farnesol, ajoene+geranylgeraniol, ajoene+me-
valonate versus control (without compounds), and simvastatin versus
control (without compounds).
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Ferri et al., 2001). Ajoene significantly inhibited [3H]-GGOH
incorporation into specific low molecular weight proteins in a
concentration-dependent manner (Figure 6). Although less
eective, we also detected a dose dependent inhibitory eect
of ajoene on [3H]-FOH incorporation (Figure 6). These data
suggest that ajoene might exert its antiproliferative eect by
interfering with protein prenylation process.
Inhibition of PFTase and PGGTas-I activity by ajoene
in vitro
To further investigate the eect of ajoene on protein
prenylation, we measured the activity of PFTase and
PGGTase-I using Ras-CVIM and H-Ras-CVLL as sub-
strates, respectively, in the absence of DTT. Ajoene inhibited
PFTase and PGGTase I reactions in a dose-dependent
manner with IC50 values of 13.0 and 6.9 mM, respectively
(Figure 7A). In the presence of 100 mM ajoene, which causes
nearly complete inhibition of both reactions, increasing
concentrations of DTT prevented the eect of ajoene, and
led to even higher activity than that observed in the absence
of both ajoene and DTT (Figure 7B). Similar inhibitory
eects of ajoene were also observed when PFTase and
PGGTase-I assays were carried out with peptide substrates
biotin-lamine B peptide (biotin-GTPRASNRSCAIS) and
biotin-g6 peptide (biotin-NPFREKKFFCAIL) (data not
shown).
Ajoene contains a disulphide bond that is reductively
cleavable by DTT (Figure 1). Thus, our results suggest that
the disulfide linkage in ajoene is an indispensable element for
the ability of the compound to inhibit PFTase and PGGTase-
I reactions.
HPLC and mass spectrometry analyses of the product(s)
from incubation of ajoene and biotin- g6 peptide
We next studied whether ajoene inhibits the prenylation
reaction by modification of the cysteine SH group of the
PGGTase-I substrate (biotin-NPFREKKFFCAIL). When a
mixture of ajoene and biotin-g6 peptide was incubated and
subjected to reverse-phase HPLC analyses, we observed the
formation of a new compound (retention time, 22.3 min) that
separated from ajoene (20.1 min) and the peptide (19.1 min)
(Figure 8A,B,C). This compound was completely removed
from the mixture by treatment with avidin-agarose prior to
HPLC analyses (Figure 8D) and was ninhydrin-test positive,
indicating that the compound is a biotinylated peptide with
modification by ajoene.
Biotin-g6 peptide contains two lysine and one arginine
residues. Electron spray mass spectrometry of this peptide
(molecular mass=1952.4) gave a major ion signal of 651.6
that corresponds to a triply charged ion ([M+3H]/3z) of the
peptide. The mass spectrum of a mixture of biotin-g6 and
ajoene showed major ion signals of 675.7, 651.6, and 781.5
Figure 6 Concentration-dependent eect of ajoene on [3H]-FOH
and [3H]-GGOH incorporation into proteins of rat aortic SMCs.
Experimental conditions are as in Figure 1B. Quiescent cells were
incubated for 20 h in a fresh medium containing 10% FCS in the
presence or absence of ajoene. [3H]-FOH (10 mM) or [3H]-GGOH
(5 mM) were added during the last 5 h of incubation. Cell pellets
were delipidated and equal amounts of cell extracts (40 mg cell
protein/lane) were separated by 12.5% SDS–PAGE and fluoro-
graphed. The data shown are representative of two independent
experiments.
Figure 7 Inhibition of PFTase and PGGTase-I reactions by ajoene
and reverse of the inhibition by DTT. (A) Rat PFTase or PGGTase-I
(20 ng protein) was incubated at 308C for 20 min with 0.75 mM
(0.3 mCi) [3H]-FPP/5 mM RAS-CVIM or 0.75 mM (0.3 mCi) [3H]-
GGPP/5 mM H-Ras-CVLL, respectively, under the standard condi-
tions. Ajoene was tested at the indicated concentrations for inhibition
of the PFTase and PGGTase-I reactions. Control levels with no
ajoene (100% activity) were 11,590 c.p.m. and 3300 c.p.m., respec-
tively, for PFTase and PGGTase-I assays. No enzyme controls (0%
activity) were 120 c.p.m. and 1500 c.p.m., respectively, for PFTase
and PGGTase-I assays. (B) Rat PFTase or PGGTase-I was incubated
as in A in the presence of 100 mM ajoene and the indicated
concentration of DTT. Activity is expressed as relative per cent to
controls with no ajoene or DTT (100% activity for PFTase assay is
8710 c.p.m. and that for PGGTase-I assay is 3320 c.p.m.).
Figure 8 C18 HPLC analyses of the product from ajoene and biotin
g6 peptide. Ajoene alone (panel A), biotin-g6 peptide (biotin-
NPFREKKFFCAIL) alone (panel B), or a mixture of ajoene
(50 mM) and biotin g6 peptide (25 mM) (panel C), was incubated at
308C for 30 min and subjected to C18 reverse-phase HPLC as
described in ‘Methods’. An identical mixture as panel C was also
chromatographed after removal of biotinylated compounds with
100 ml of avidin-agarose gel (panel D). The elution was carried out by
a gradient of acetonitrile concentrations from 20 to 80% over
60 min.
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(Figure 9A). The 651.6 signal corresponds to the triply
charged peptide, and the 781.5 signal corresponds to an ion
of dimerized peptide ([2M+5H]/5z) linked via a disulphide
bridge since this signal disappeared when incubated with
DTT (Figure 9B). The 675.7 signal is a triply charged ion of
a compound with molecular mass of 2041.1, which is 71.7
mass unit larger than that of biotin-g6 peptide and
corresponds to the peptide covalently modified with
CH2=CHCH2-S-, a portion of ajoene. The 675.7 signal
was greatly reduced by further incubation with 50 mM DTT
(Figure 9B), showing that this compound is the peptide
attached via a disulphide to CH2=CHCH2-S-. The minor
mass signal of 705 formed in the mixture (Figure 9A) may be
a triply charged ion of a compound with molecular mass of
2112 that is 159.6 unit larger than the peptide, suggesting that
the peptide may also be modified with the larger portion of
ajoene CH2=CHCH2S(O)CH2CH=CH-S-, but with about 4
fold less eciency compared to modification with
CH2=CHCH2-S-. These results suggest that the cysteine
SH group of the peptide is modified with the fragments
(preferentially with the smaller one CH2=CHCH2-S-) of
ajoene by disulphide bond. Preferential labelling of the
peptide with the 3-carbon portion of ajoene is expected, as
the vinyl thiolate fragment is a better leaving group than is
the allylic thiolate. This blockage of the SH group(s) of
protein prenyltransferase substrates may be the mechanism
by which ajoene inhibits prenyl modification of proteins in
SMCs.
Discussion and conclusion
In the present study we have evaluated the eect of synthetic
ajoene, an organosulphur compound derived from garlic, on
SMCs proliferation as related to protein prenylation.
Incubation of SMCs with ajoene showed a dose dependent
inhibition of cell proliferation and thymidine incorporation
(Figure 2A and B). Cell cycle analysis also demonstrated that
ajoene specifically blocks the cell cycle in G1 phase, leading
to the accumulation of the cells in the G0/G1 (Figure 3).
The inhibitory eects on the G1 phase observed in cells
treated with HMG-CoA reductase inhibitors (Jakobisiak et
al., 1991), with PFTase inhibitors (Sepp-Lorenzino & Rosen,
1998), with PGGTase I inhibitors (Stark et al., 1998), and
with a dual PFTase and PGGTases inhibitor (Ferri et al.,
2001), suggest the involvement of specific isoprenoids
metabolites in the regulation of the G1/S phase transition
of the cell cycle. The addition of MVA, all-trans FOH and
all-trans GGOH, precursors of prenylated proteins, restored
cell proliferation inhibited by HMG-CoA reductase inhibitors
(statins) (Figure 5B) (Corsini et al., 1993), but not by the
protein prenylation inhibitor perillic acid (Ferri et al., 2001),
further confirming a specific role of isoprenoids in regulating
cell proliferation (Raiteri et al., 1997). Similar to perillic acid,
MVA or its isoprenoids derivatives (FOH or GGOH) did not
counteract ajoene-induced blockade of SMC proliferation
(Figure 5A). These results suggest that ajoene might inhibit
protein prenylation. In fact, analysis of the incorporation of
radiolabelled all-trans FOH and all-trans GGOH into cellular
proteins, demonstrated that ajoene reduces the incorporation
of both prenols, with a more marked eect on [3H]-GGOH.
However, in contrast to perillic acid, ajoene not only aects
protein prenylation, but also exerted a strong inhibition of
cholesterol biosynthesis. Nevertheless, because ajoene’s eect
on SMC proliferation was not counteracted by MVA and its
isoprenoids derivatives, and in contrast to simvastatin, was
observed at concentrations similar to those required for
inhibiting cholesterol biosynthesis, ajoene’s action is more
likely due to a decrease in protein prenylation than a decrease
of HMG-CoA reductase activity (Gebhardt et al., 1994).
To date, three classes of enzymes, protein farnesyltransfer-
ase (PFTase) and protein geranylgeranyltransferases
(PGGTase I and II) have been identified in mammals to
catalyse the transfer of prenyl groups to the sulphur atom of
the cysteine residue located at fourth amino acid from the
carboxyl terminus of the proteins (CAAX domain; where the
C is a cysteine, the two A residues are aliphatic amino acids,
and the X can be methionine, serine, alanine, glutamine or
leucine) (Casey & Seabra, 1996). We used an in vitro assay to
further investigate the eect of ajoene on protein prenylation,
and showed a significant inhibition of both PFTase and
PGGTase-I activity by ajoene. Interestingly, the concentra-
tions required for inhibiting SMC proliferation, PFTase, and
PGGTase-I activities are similar (IC50=5.7, 6.9, and 13.0 mM
respectively). Furthermore, a significant reduction of the
incorporation of [3H]-FOH and [3H]-GGOH into proteins,
Figure 9 Mass spectrometry analyses of the product from ajoene
and biotin g6 peptide. (Panel A) The mixture of ajoene (50 mM) and
biotin g6 peptide (biotin-NPFREKKFFCAIL) (25 mM) was incubated
at 308C for 30 min and subjected to mass spectrometry analysis as
described in ‘Methods’. (Panel B) The same mixture as in Panel A
was further incubated with 50 mM DTT at 308C for 30 min.
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was observed in the presence of 10 – 25 mM ajoene. These data
illustrate a correlation between the eect of ajoene on cell
proliferation and protein prenylation.
The fact that the inhibitory eects of ajoene on PFTase
and PGGTase-I activity were blocked by DTT (Figure 7B)
suggests the possibility that ajoene modifies the substrate at
the SH group of cysteine. Accordingly, HPLC and mass
spectrometry analyses, showed the formation of adducts
between the cysteine SH group of the CAAX peptide (biotin-
g6) and fragments of ajoene. These results led us to postulate
that ajoene might interfere with protein prenylation by a
covalent modification of the cysteine residue of protein
substrates without a specific inhibitory eect on PFTase
and/or PGGTase-I. The more marked inhibitory eect of
ajoene on [3H]-GGOH versus [3H]-FOH incorporation into
cellular proteins could be due to dierences in the
intracellular pool sizes of farnesyl pyrophosphate (FPP),
and geranylgeranyl pyrophosphate (GGPP) (Corsini et al.,
1999).
Although this is the first report showing the eect of ajoene
on protein prenylation, our study is in agreement with the
evidence that ajoene inhibits the activity of protein tyrosine
phosphatases in platelets, which is a class of molecules that
undergo farnesylation (Cates et al., 1996; Villar et al., 1997).
It is noteworthy to mention that organosulphuric compounds
derived from garlic, containing the disulphide moiety, or an
active thioallyl group, have been shown to react in vitro and
in vivo with cysteine to form S-allyl mercaptocysteine adducts
(Weisberger & Pensky, 1958). It has also been shown that
ajoene alters glutathione metabolism, (Scharfenberg et al.,
1994), and that removal of the sulphide group of ajoene
induces a 2 fold decrease in its ability to suppress collagen-
induced platelet aggregation (Block et al., 1986).
Although the antiproliferative eects of ajoene have
received little attention, a recent study shows that Z-ajoene
is able to inhibit HL60 cells proliferation and tumour growth
in vivo. The eect seems to be due to a specific inhibition of
micotubules formation mediated by ajoene, and therefore a
blockage of the transition of the G2/M phase of the cell cycle
(Li et al., 2002). Although it is possible that multiple
mechanisms of action can contribute to the antiproliferative
eect of ajoene, the discrepancy between our results and the
above study can potentially be explained by a specific eect
of Z-ajoene versus a mixture of the isomers utilized in our
study, or by the dierent cell type investigated. It is also
important to note that, although ajoene can induce apoptosis
in the human promyelcytic leukemia cell line HL-60, we did
not observed hypodiploid cells in SMCs (Dirsch et al., 1998;
Li et al., 2002). Dierent susceptibility of the cells to undergo
apoptosis can account for the discrepancy between these
observations, since ajoene does not induce apoptosis in
peripheral blood mononuclear cells isolated from healthy
humans (Dirsch et al., 1998).
In conclusion we show that ajoene, a synthetic garlic
component, inhibits protein prenylation and SMCs prolifera-
tion. We demonstrate that ajoene, by covalent reaction, leads
to covalent modification of the cysteine SH group of the
CAAX motif of protein prenyl group acceptors, an eect
which may contributes to the ability of ajoene to inhibit SMC
proliferation.
The Esquire mass spectrometer was purchased with support by
National Science Foundation under Grant No. 9807748. This work
was partially supported by FIRST 2002 project ‘Eect of
inhibitors of farnesyl and geranylgeranyltransferase on vasal
myocytes proliferation’.
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